Javascript must be enabled to continue!
Factors Affecting the Accuracy of Estimation of BEV Cruising Range
View through CrossRef
Abstract
As the number of electric vehicles is increasing year by year, the accuracy of electric vehicle cruising range estimation in high and low temperature environments is one of the performances that consumers are very concerned about. In this paper, the accuracy of cruising range estimation is evaluated by the determination of coefficient, and the influence of ambient temperature on the estimation accuracy of cruising range is deeply studied. Eleven electric vehicles were selected to carry out the cruising range test at normal temperature, high temperature and low temperature respectively, and the influence law at ambient temperature of the accuracy of cruising range estimation was obtained. At the same time, the influence of the self-learning function on the accuracy of the cruising range estimation is also studied. Finally, the performance of the estimation of accuracy of the end mileage at different ambient temperatures is analyzed.
Title: Factors Affecting the Accuracy of Estimation of BEV Cruising Range
Description:
Abstract
As the number of electric vehicles is increasing year by year, the accuracy of electric vehicle cruising range estimation in high and low temperature environments is one of the performances that consumers are very concerned about.
In this paper, the accuracy of cruising range estimation is evaluated by the determination of coefficient, and the influence of ambient temperature on the estimation accuracy of cruising range is deeply studied.
Eleven electric vehicles were selected to carry out the cruising range test at normal temperature, high temperature and low temperature respectively, and the influence law at ambient temperature of the accuracy of cruising range estimation was obtained.
At the same time, the influence of the self-learning function on the accuracy of the cruising range estimation is also studied.
Finally, the performance of the estimation of accuracy of the end mileage at different ambient temperatures is analyzed.
Related Results
Abstract P5-17-07: Influence of bevacizumab on local-regional recurrence in triple negative breast cancer
Abstract P5-17-07: Influence of bevacizumab on local-regional recurrence in triple negative breast cancer
Abstract
Background: Triple negative breast cancer (TNBC) comprises 15–20% of newly diagnosed invasive breast cancers and has been associated with an elevated risk o...
P14.15 Benefit of Bevacizumab for recurrent glioblastoma. Results of 81 patients from a single institution
P14.15 Benefit of Bevacizumab for recurrent glioblastoma. Results of 81 patients from a single institution
Abstract
BACKGROUND
No standard of care has been established for patients with progressive glioblastoma (rGBM). Previous studies...
BIPM.EM-K11 comparison of 1.018 V and 10 V Standards between the BEV (Austria) and the BIPM, April to May 2025
BIPM.EM-K11 comparison of 1.018 V and 10 V Standards between the BEV (Austria) and the BIPM, April to May 2025
Main text
As part of the ongoing BIPM key comparison BIPM.EM-K11, a comparison of the 1.018 V and 10 V voltage reference standards of the BIPM and the Bundesamt für ...
NIMG-58. PET IMAGING AS A RELIABLE INDICATOR FOR EVALUATING BEVACIZUMAB TREATMENT RESPONSE IN GBM
NIMG-58. PET IMAGING AS A RELIABLE INDICATOR FOR EVALUATING BEVACIZUMAB TREATMENT RESPONSE IN GBM
Abstract
OBJECTIVE
PET scans are crucial for glioma diagnosis and treatment planning, but assessing the efficacy of Bevacizumab ...
P3-04-02: Bevacizumab Treatment Alters Intrinsic Subtypes in a VEGF-Reinforced Xenograft Model of ER-Positive Breast Cancer.
P3-04-02: Bevacizumab Treatment Alters Intrinsic Subtypes in a VEGF-Reinforced Xenograft Model of ER-Positive Breast Cancer.
Abstract
Background: Anti-vascular endothelial growth factor (anti-VEGF) therapy improves disease-free but not overall survival in metastatic breast cancer. To seek ...
ANGI-1 ASSESSING THE THERAPEUTIC EFFECT OF BEVACIZUMAB USING FMISO-PET IN GBM THERAPY
ANGI-1 ASSESSING THE THERAPEUTIC EFFECT OF BEVACIZUMAB USING FMISO-PET IN GBM THERAPY
Abstract
Background
Gd-enhanced MRI and T2WI/FLAIR images are used to determine the efficacy of bevacizumab(Bev) in glioblastoma...
Real-world outcomes of stereotactic body radiotherapy plus sintilimab and bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus
Real-world outcomes of stereotactic body radiotherapy plus sintilimab and bevacizumab for hepatocellular carcinoma with portal vein tumor thrombus
Abstract
Background
Sintilimab plus bevacizumab (Sin + Bev) is recommended as a first-line treatment for hepatocellular c...
Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response
Experimental immunization of mice with a recombinant bovine enterovirus vaccine expressing BVDV E0 protein elicits a long-lasting serologic response
AbstractBackgroundBovine viral diarrhea virus (BVDV) is a cause of substantial economic loss to the cattle industry worldwide, and there are currently no effective treatment or pre...

